Grieve AP - Search Results

1

How to design a dose-finding study using the continual reassessment method.

Wheeler GM, Mander AP, Bedding A, Brock K, Cornelius V, Grieve AP, Jaki T, Love SB, Odondi L, Weir CJ, Yap C, Bond SJ. Wheeler GM, et al. Among authors: grieve ap. BMC Med Res Methodol. 2019 Jan 18;19(1):18. doi: 10.1186/s12874-018-0638-z. BMC Med Res Methodol. 2019. PMID: 30658575 Free PMC article.

2

Flexible design and efficient implementation of adaptive dose-finding studies.

Weir CJ, Spiegelhalter DJ, Grieve AP. Weir CJ, et al. Among authors: grieve ap. J Biopharm Stat. 2007;17(6):1033-50. doi: 10.1080/10543400701643947. J Biopharm Stat. 2007. PMID: 18027215

3

The association of post-stroke neurological improvement with risk of subsequent deterioration due to stroke events.

Aslanyan S, Weir CJ, Johnston CS, Krams M, Grieve AP, Lees KR. Aslanyan S, et al. Among authors: grieve ap. Eur J Neurol. 2007 Jan;14(1):1-6. doi: 10.1111/j.1468-1331.2006.01549.x. Eur J Neurol. 2007. PMID: 17222105 Clinical Trial.

4

Potential application of item-response theory to interpretation of medical codes in electronic patient records.

Dregan A, Grieve A, van Staa T, Gulliford MC; eCRT Research Team. Dregan A, et al. BMC Med Res Methodol. 2011 Dec 16;11:168. doi: 10.1186/1471-2288-11-168. BMC Med Res Methodol. 2011. PMID: 22176509 Free PMC article.

5

Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practice.

Bird SM, Bailey RA, Grieve AP, Senn S. Bird SM, et al. Among authors: grieve ap. Pharm Stat. 2017 Mar;16(2):100-106. doi: 10.1002/pst.1801. Epub 2017 Feb 16. Pharm Stat. 2017. PMID: 28206702 Free PMC article.

6

A comment on optimal allocations for bioequivalence studies.

Senn S, Grieve AP. Senn S, et al. Among authors: grieve ap. Biometrics. 1999 Dec;55(4):1314-5. doi: 10.1111/j.0006-341x.1999.01314.x. Biometrics. 1999. PMID: 11315090

7

Implementation of a Bayesian adaptive design in a proof of concept study.

Smith MK, Jones I, Morris MF, Grieve AP, Tan K. Smith MK, et al. Among authors: grieve ap. Pharm Stat. 2006 Jan-Mar;5(1):39-50. doi: 10.1002/pst.198. Pharm Stat. 2006. PMID: 17080927

8

Discussion of the "White Paper of the PhRMA Working Group on adaptive dose-ranging designs".

Grieve AP. Grieve AP. J Biopharm Stat. 2007;17(6):997-1004; discussion 1029-32. doi: 10.1080/10543400701643855. J Biopharm Stat. 2007. PMID: 18027209 No abstract available.

9

Optimising the trade-off between type I and II error rates in the Bayesian context.

Walley RJ, Grieve AP. Walley RJ, et al. Among authors: grieve ap. Pharm Stat. 2021 Jul;20(4):710-720. doi: 10.1002/pst.2102. Epub 2021 Feb 22. Pharm Stat. 2021. PMID: 33619884

10

ASTIN: a Bayesian adaptive dose-response trial in acute stroke.

Grieve AP, Krams M. Grieve AP, et al. Clin Trials. 2005;2(4):340-51; discussion 352-8, 364-78. doi: 10.1191/1740774505cn094oa. Clin Trials. 2005. PMID: 16281432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters